摘要
目的:由于炎性乳腺癌发病罕见,且初始症状常为炎症表现,在诊疗过程中常常被误诊、漏诊,本文通过1例炎性乳腺癌新辅助化疗病例及文献复习,进一步提高对炎性乳腺癌的认识。方法:回顾性分析1例临床分期为T4dN1M0的炎性乳腺癌患者,新辅助化疗后行乳腺癌根治术,术后行放疗加内分泌治疗,观察其疗效,并回顾分析相关文献。结果:该炎性乳腺癌患者经新辅助化疗 + 手术、放疗 + 内分泌治疗,随诊至今患者暂无转移复发。
Objective: Because inflammatory breast cancer is rare, and the initial symptom is often inflamma-tion, it is often misdiagnosed and missed in the diagnosis and treatment process. This article will further improve the understanding of inflammatory breast cancer through a case of inflammatory breast cancer with neoadjuvant chemotherapy and a literature review. Methods: A case of inflam-matory breast cancer with the clinical stage of T4dN1M0 was retrospectively analyzed. After neo-adjuvant chemotherapy, radical mastectomy was performed, followed by radiotherapy and endo-crine therapy. The efficacy was observed and the related literature was reviewed. Results: After neoadjuvant chemotherapy, surgery, radiotherapy, endocrinotherapy, the patient has no metasta-sis and recurrence.
出处
《临床医学进展》
2022年第10期9564-9568,共5页
Advances in Clinical Medicine
